• About napwha
  • About this site
  • Contact Us
  • Subscribe
  • napwha website
HIV Cure

Find out about current studies

Get Involved
  • Home
  • Science
    • Reservoir, Remission, Rebound
    • Latency Reversing Agents
    • Gene Therapy
    • Vaccines
    • Novel Approaches
    • Research Spotlight
  • Clinical Trials
    • Get Involved
  • Community
  • Media
  • Video

Inclusion, Respect, Equity: A photo essay of people participating in HIV cure research at The Alfred in Victoria.

2 days ago NAPWHA Community, Media, Research Spotlight

This beautiful photographic essay was compiled by The Alfred in Melbourne, and all credit for this article goes to their amazing teams and the people they care for. This article is shared with permission of The Alfred. Working together with researchers and clinicians at The Alfred, members of the community of people living with HIV…

Dr Jesper D Gunst, PhD, Dr Thomas A. Rasmussen, PhD, Associate Professor, and Dr Ole S. Søgaard, PhD

Broadly neutralizing antibodies (bNABs) as a component of an HIV cure: results from the TITAN study

3 months ago NAPWHA bNABs, Novel Approaches

Drs Jesper D. Gunst PhD, Thomas A. Rasmussen PhD and Ole S. Søgaard PhD of Aarhus University Hospital, Denmark share the results of the TITAN study exploring bNABs towards an HIV cure with NAPWHA, ahead of publication in Nature Magazine on the 11th of September. The TITAN study is the first HIV cure study of…

By Dr Jillian Lau

Cure update from IAS 2023  

3 months ago NAPWHA Community, Reservoir, Remission, Rebound

Dr Jillian Lau of the Doherty Institute and Alfred Health in Melbourne attended the recent IAS (International AIDS Society) HIV Cure and Immunotherapy preconference in Brisbane.  Dr Lau also acted as rapporteur for the preconference, along with Ellen Bowden-Reid, a PhD candidate from the Kirby Institute, Sydney. Dr Lau has kindly compiled this report for…

By Kiho Tanaka, Youry Kim and Michael Roche

Reversing latency to cure HIV

6 months ago NAPWHA Latency Reversing Agents, Reservoir, Remission, Rebound
person looking at night sky

HIV is a virus that inserts its own DNA into the host DNA upon infection. This “provirus” can remain dormant, or latent, for a long time. Proviruses are the source of new viruses causing viral rebound if antiretroviral therapy (ART) is stopped. This means treatment is a lifelong proposition for people living with HIV (PLWH)….

By Mihiri Weerasuria and Heather Ellis

Why we need more women in HIV cure trials

8 months ago NAPWHA Community
Three women smiling at camera - while we need more women in HIV cure trials

As the search for the elusive cure for HIV continues, researchers must take a lesson from the humble car safety airbag. Just like the airbag, HIV impacts women differently to men. The well-intentioned scientists who first developed the airbag initially tested it against crash test dummies based on the “average-sized male”. In the real world…

Read the Winter Issue of Positive Living Here

5 years ago NAPWHA Community

In the winter issue of Positive Living we’ve four takeaways from CROI — plus why talk of a cure is premature. In an era of U=U and TasP, we ask: are the long-term survivors the forgotten generation? Meanwhile, David Menadue reviews two films that portray the early days of HIV; Dr Louise returns with What’s…

Read the spring issue of Positive Living here

5 years ago NAPWHA Community

In the spring issue of Positive Living, all things AIDS 2018. We’ve an overview of the conference itself, and antipodean activists and advocates share their impressions. We report from Indonesia, where the country’s anti-LGBT agenda is having a devastating impact on its HIV response. To mark 30 years since the introduction of AZT to Australia,…

Checkpoint blockade restores NK cell function

5 years ago NAPWHA Research Spotlight
Traffic lights

Does immune checkpoint blockade have indirect effects on cells other than CD4 T cells? Filippos Porichis and colleagues have studied this question in a series of experiments on cells from people living with HIV. They show that blocking both PD-1 and IL-10 restores function to helper CD4 T cells. These reinvigorated helper cells can then…

Sex hormone receptors regulate HIV latency

5 years ago NAPWHA Research Spotlight
Estradiol

New research suggests that the estrogen receptor (ESR-1) is important in controlling HIV latency. In lab models of latent HIV and in cells from people living with HIV, researchers studied the effects of compounds binding to ESR-1. The sex hormone estradiol strongly blocked HIV reactivation. Non-hormonal drugs that bind ESR-1 were weak HIV activators that…

Antibody can act as a B cell blocker

5 years ago NAPWHA Research Spotlight
Antibody

Researchers have discovered a type of antibody that blocks normal immune responses in chronic HIV infection. NIH researchers studied blood samples from people at different stages of HIV infection and compared them with samples from people without HIV. They found that a type of antibody called immunoglobulin G3 (IgG3) hangs around in the blood of…

Page 1 of 712345...»Last »

Inclusion, Respect, Equity: A photo essay of people participating in HIV cure research at The Alfred ...

This beautiful photographic essay was compiled by The Alfred in Melbourne, and all credit for this article goes to their amazing teams and the people they care for. This article is shared with permission of The Alfred.

Alfred Health

Working together with researchers and clinicians at The Alfred, members of the community of people living with HIV in Victoria have been integral to progressing ...

Trust crucial to treatment interruption

Gene therapy advance in mice

New sequencing method shows many blood-derived HIV particles are defective

High CD4 count before HIV treatment contributes to smaller HIV reservoir on ART

  • 2023
  • 2022
  • 2021
  • 2020
  • 2019
  • 2018
  • 2017
  • 2016
  • 2015
  • 2014
  • 2012

Supported by


Supported by the National Institute Of Allergy And Infectious Diseases of the National Institutes of Health under Award Number U19AI096109. The content is solely the responsibility of the authors and does not necessarily represent the official views of the National Institutes of Health.

About NAPWHA

Founded in 1989, The National Association of People with HIV Australia (NAPWHA) is Australia’s peak non-government organisation representing community-based groups of people living with HIV (PLHIV).
Copyright (c) 2023. National Association of people with HIV Australia. ABN: 79 052 437 899